Robert F Gagel

Robert F Gagel

UNVERIFIED PROFILE

Are you Robert F Gagel?   Register this Author

Register author
Robert F Gagel

Robert F Gagel

Publications by authors named "Robert F Gagel"

Are you Robert F Gagel?   Register this Author

90Publications

1635Reads

38Profile Views

Oncogenic and osteolytic functions of histone demethylase NO66 in castration-resistant prostate cancer.

Oncogene 2019 Jun 11;38(25):5038-5049. Epub 2019 Mar 11.

Department of Orthopaedic Surgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41388-019-0774-xDOI Listing
June 2019

Tumor-induced hypophosphatemic osteomalacia caused by a mesenchymal tumor of the mandible managed by a segmental mandibulectomy and microvascular reconstruction with a free fibula flap.

Head Neck 2019 Jun 11;41(6):E93-E98. Epub 2019 Mar 11.

Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.25657DOI Listing
June 2019

Combinations of Tyrosine Kinase Inhibitor and ERAD Inhibitor Promote Oxidative Stress-Induced Apoptosis through ATF4 and KLF9 in Medullary Thyroid Cancer.

Mol Cancer Res 2019 03 14;17(3):751-760. Epub 2018 Dec 14.

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://mcr.aacrjournals.org/lookup/doi/10.1158/1541-7786.MCR
Publisher Site
http://dx.doi.org/10.1158/1541-7786.MCR-18-0354DOI Listing
March 2019

Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer.

Endocr Relat Cancer 2019 02;26(2):241-250

Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
https://erc.bioscientifica.com/view/journals/erc/26/2/ERC-18
Publisher Site
http://dx.doi.org/10.1530/ERC-18-0258DOI Listing
February 2019

Fractures frequently occur in older cancer patients: the MD Anderson Cancer Center experience.

Support Care Cancer 2018 May 2;26(5):1561-1568. Epub 2017 Dec 2.

Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-017-3962-7DOI Listing
May 2018

Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma.

J Clin Endocrinol Metab 2016 12 23;101(12):4871-4877. Epub 2016 Sep 23.

Departments of Endocrine Neoplasia and Hormonal Disorders (J.Y.X., C.J., S.N.R., M.A.H., S.G.W., R.D., R.F.G., A.K.Y., M.E.C., S.P.W., N.L.B., R.V.S., S.I.S., M.I.H.), Radiology (W.A.M.), Biostatistics (D.R.M.), and Endocrine Surgery (E.G.), University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1402.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2016-2815DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155685PMC
December 2016

Medullary Thyroid Carcinoma Associated with Germline RET Mutation.

Thyroid 2016 12 18;26(12):1744-1751. Epub 2016 Oct 18.

1 Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center , Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/thy.2016.0374DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175438PMC
December 2016

Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma.

Thyroid 2016 11 18;26(11):1553-1562. Epub 2016 Oct 18.

4 Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center , Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/thy.2016.0224DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453497PMC
November 2016

The National Osteoporosis Foundation's methods and processes for developing position statements.

Arch Osteoporos 2016 26;11:22. Epub 2016 May 26.

Department of Obstetrics and Gynecology, MedStar Georgetown University Hospital, Washington, DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11657-016-0276-1DOI Listing
October 2016

Ibandronate for the prevention of bone loss after allogeneic stem cell transplantation for hematologic malignancies: a randomized-controlled trial.

Bonekey Rep 2016 19;5:843. Epub 2016 Oct 19.

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bonekey.2016.72DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154364PMC
October 2016

Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma.

Sci Transl Med 2016 08;8(353):353ra113

Department of Lymphoma and Myeloma, Division of Cancer Medicine, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.aad8949DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109917PMC
August 2016

Use of Tyrosine Kinase Inhibitors for Treatment of Medullary Thyroid Carcinoma.

Recent Results Cancer Res 2015 ;204:227-49

Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, 1461, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-22542-5_11DOI Listing
March 2016

My, How Things Have Changed in Multiple Endocrine Neoplasia Type 2A!

J Clin Endocrinol Metab 2015 Jul;100(7):2532-5

Departments of Surgical Oncology (E.G.G.) and Endocrine Neoplasia and Hormonal Disorders (R.F.G.), University of Texas MD Anderson Cancer Center, Houston, Texas 77030.

View Article

Download full-text PDF

Source
https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.
Publisher Site
http://dx.doi.org/10.1210/jc.2015-2516DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393525PMC
July 2015

Treatment of osteoporosis is not futile.

BMJ 2015 Jul 14;351:h3274. Epub 2015 Jul 14.

National Bone Health Alliance, Washington DC 20036, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmj.h3274DOI Listing
July 2015

A miRNA signature associated with human metastatic medullary thyroid carcinoma.

Endocr Relat Cancer 2013 Dec 14;20(6):809-23. Epub 2013 Oct 14.

Departments of Endocrine Neoplasia and Hormonal Disorders Experimental Therapeutics Urology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA Department of Oncology, The University of Naples, Naples, Italy Department of Pathology, Centro Oncologico Fiorentino, Sesto Fiorentino, Florence, Italy Verna and Marrs McLean Department of Biochemistry and Molecular Biology Baylor College of Medicine, Houston, Texas, USA Department of Oncology, Istituto Toscano Tumori, Hospital of Prato, Prato, Italy Department of Gynecologic Oncology, Center for RNA Interference and Non-coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Department of Endocrinology, University of Messina, Messina, Italy Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA Department of Internal Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-13-0357DOI Listing
December 2013

The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2.

J Clin Endocrinol Metab 2013 Nov 12;98(11):E1813-9. Epub 2013 Sep 12.

MD, AssociateDepartment of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street Unit 1461, Houston, TX 77030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2013-1653DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399523PMC
November 2013

The noninvestigational use of tyrosine kinase inhibitors in thyroid cancer: establishing a standard for patient safety and monitoring.

J Clin Endocrinol Metab 2013 Jan 26;98(1):31-42. Epub 2012 Nov 26.

Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Baylor College of Medicine, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2012-2909DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3537108PMC
January 2013

Activation of G-protein-coupled receptors and thyroid malignant tumors: the jury is still out.

Authors:
Robert F Gagel

Endocr Pract 2011 Nov-Dec;17(6):957-9

View Article

Download full-text PDF

Source
May 2012

Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients.

Ann N Y Acad Sci 2011 Feb 28;1218:47-54. Epub 2010 Sep 28.

Department of Endocrinology, Fleury Group, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1749-6632.2010.05771.xDOI Listing
February 2011

The evolving field of tyrosine kinase inhibitors in the treatment of endocrine tumors.

Endocr Rev 2010 Aug 6;31(4):578-99. Epub 2010 Jul 6.

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M. D. Anderson Cancer Center, Houston, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/er.2009-0031DOI Listing
August 2010

Cancer therapies and bone health.

Curr Rheumatol Rep 2010 Jun;12(3):177-85

Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas M. D. Anderson Cancer Center, 1400 Pressler Street, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11926-010-0098-xDOI Listing
June 2010

Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer.

J Clin Oncol 2010 Feb 11;28(5):767-72. Epub 2010 Jan 11.

Dept of Surgery, Washington University School of Medicine, Box 8109, 660 S Euclid Ave, St Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.23.6604DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834392PMC
February 2010

Targeted therapy for endocrine cancer: the medullary thyroid carcinoma paradigm.

Endocr Pract 2009 Sep-Oct;15(6):597-604

Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4158/EP09148.RARDOI Listing
January 2010

Phase I trial of a combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in advanced malignancies.

Clin Cancer Res 2009 Nov 10;15(22):7061-8. Epub 2009 Nov 10.

Division of Cancer Medicine, Department of Investigational Therapeutics (Phase 1 Program), Unit 455, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-1241DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784003PMC
November 2009

The calcitonin/calcitonin gene related peptide-alpha gene is not required for 1alpha,25-dihydroxyvitamin D3-mediated suppression of experimental autoimmune encephalomyelitis.

Arch Biochem Biophys 2009 Aug 27;488(2):105-8. Epub 2009 Jun 27.

Department of Biochemistry, University of Wisconsin-Madison, Madison, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.abb.2009.06.015DOI Listing
August 2009

Medullary thyroid cancer: management guidelines of the American Thyroid Association.

Thyroid 2009 Jun;19(6):565-612

Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, The Ohio State University, The Arthur G. James Cancer Hospital, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/thy.2008.0403DOI Listing
June 2009

NCCN Task Force Report: Bone Health in Cancer Care.

J Natl Compr Canc Netw 2009 Jun;7 Suppl 3:S1-32; quiz S33-5

Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047404PMC
http://dx.doi.org/10.6004/jnccn.2009.0076DOI Listing
June 2009

Diabetes insipidus and panhypopituitarism due to intrasellar metastasis from medullary thyroid cancer.

Head Neck 2009 Mar;31(3):419-23

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hed.20911
Publisher Site
http://dx.doi.org/10.1002/hed.20911DOI Listing
March 2009

Follow-up of pituitary tumor volume in patients with acromegaly treated with pegvisomant in clinical trials.

Eur J Endocrinol 2008 Nov 15;159(5):517-23. Epub 2008 Aug 15.

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/EJE-08-0205DOI Listing
November 2008

High resolution array-comparative genomic hybridization profiling reveals deoxyribonucleic acid copy number alterations associated with medullary thyroid carcinoma.

J Clin Endocrinol Metab 2008 Nov 2;93(11):4367-72. Epub 2008 Sep 2.

Department of Endocrine Neoplasia and Hormonal Disorders, Unit 433, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.
Publisher Site
http://dx.doi.org/10.1210/jc.2008-0912DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2729231PMC
November 2008

Four patients with cutaneous metastases from medullary thyroid cancer.

Thyroid 2008 Aug;18(8):901-5

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/thy.2007.0179DOI Listing
August 2008

Management of medullary thyroid carcinoma.

Endocrinol Metab Clin North Am 2008 Jun;37(2):481-96, x-xi

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Unit 435, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ecl.2008.03.001DOI Listing
June 2008

Bone loss in patients with breast or prostate cancer.

Curr Osteoporos Rep 2007 Dec;5(4):170-8

Department of Endocrine Neoplasia, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 435, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
December 2007

Calcitonin plays a critical role in regulating skeletal mineral metabolism during lactation.

Endocrinology 2006 Sep 4;147(9):4010-21. Epub 2006 May 4.

Faculty of Medicine-Endocrinology, Memorial University of Newfoundland, 300 Prince Philip Drive, St. John's, Newfoundland, Canada A1B 3V6.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/en.2005-1616DOI Listing
September 2006

Review: Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes?

J Clin Endocrinol Metab 2006 Aug 30;91(8):2851-8. Epub 2006 May 30.

Instituto Nacional de Cancerología, Fundación Santafé de Bogotá, Colombia, South America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2005-2178DOI Listing
August 2006

Thyrotoxicosis after denileukin diftitox therapy in patients with mycosis fungoides.

J Clin Endocrinol Metab 2006 Jun 4;91(6):2205-8. Epub 2006 Apr 4.

Department of Dermatology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 434, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2005-2839DOI Listing
June 2006

Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1.

World J Surg 2006 May;30(5):643-53

Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Unit 444, 1400 Holcombe Boulevard, Houston, Texas 77030-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00268-006-0360-yDOI Listing
May 2006

Teriparatide [human PTH(1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis.

J Bone Miner Res 2006 Mar 11;21(3):354-65. Epub 2005 Nov 11.

Department of Genetics and Complex Diseases, Harvard School of Public Health, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1359/JBMR.051023DOI Listing
March 2006

Glucose homeostasis and safety in patients with acromegaly converted from long-acting octreotide to pegvisomant.

J Clin Endocrinol Metab 2005 Oct 2;90(10):5684-91. Epub 2005 Aug 2.

Department of Internal Medicine, University of Michigan Medical Center, 3920 Taubman Center, Ann Arbor, Michigan 48109-0354, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2005-0331DOI Listing
October 2005

Primary hyperparathyroidism and osteosarcoma: examination of a large cohort identifies three cases of fibroblastic osteosarcoma.

J Bone Miner Res 2005 Sep 9;20(9):1562-8. Epub 2005 May 9.

Department of Endocrinology, Diabetes, and Metabolism, Baylor College of Medicine, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1359/JBMR.050507DOI Listing
September 2005

RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors.

Thyroid 2005 Jun;15(6):531-44

Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77230-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/thy.2005.15.531DOI Listing
June 2005

Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1.

Arch Surg 2005 Apr;140(4):374-82

Department of Surgical Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, 77230-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archsurg.140.4.374DOI Listing
April 2005

Osteoporosis in breast and prostate cancer survivors.

Oncology (Williston Park) 2005 Apr;19(5):651-8

Department of Endocrine Neoplasia and Hormonal Disorders, M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
April 2005

Decreased bone formation and osteopenia in mice lacking alpha-calcitonin gene-related peptide.

J Bone Miner Res 2004 Dec 20;19(12):2049-56. Epub 2004 Sep 20.

Department of Trauma, Hand, and Reconstructive Surgery, Hamburg University School of Medicine, Martinistrasse 52, Hamburg 20246, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1359/JBMR.040915DOI Listing
December 2004

Ablation of calcitonin/calcitonin gene-related peptide-alpha impairs fetal magnesium but not calcium homeostasis.

Am J Physiol Endocrinol Metab 2004 Aug 23;287(2):E218-26. Epub 2004 Mar 23.

Faculty of Medicine-Endocrinology, Memorial University of Newfoundland, St. John's, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpendo.00023.2004DOI Listing
August 2004

Parathyroid carcinoma: a 22-year experience.

Head Neck 2004 Aug;26(8):716-26

joint Baylor College of Medicine/The University of Texas M. D. Anderson Cancer Center Training Program in Endocrinology, Diabetes, and Metabolism, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.20049DOI Listing
August 2004

Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation.

J Clin Endocrinol Metab 2004 Aug;89(8):4142-5

The University of Texas MD Anderson Cancer Center, Department of Endocrine Neoplasia and Hormonal Disorders, 1515 Holcombe Boulevard, Unit 435, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2004-0041DOI Listing
August 2004

A novel point mutation of the RET protooncogene involving the second intracellular tyrosine kinase domain in a family with medullary thyroid carcinoma.

J Clin Endocrinol Metab 2004 Jul;89(7):3521-6

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 435, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2004-0073DOI Listing
July 2004

Genetic testing in endocrinology: lessons learned from experience with multiple endocrine neoplasia type 2 (MEN2).

Growth Horm IGF Res 2004 Jun;14 Suppl A:S150-7

Division of Internal Medicine, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M.D. Anderson Cancer Center, Box 433, 1515 Holcombe Blvd., Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ghir.2004.03.033DOI Listing
June 2004

Surgical management of hereditary pheochromocytoma.

J Am Coll Surg 2004 Apr;198(4):525-34; discussion 534-5

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jamcollsurg.2003.12.001DOI Listing
April 2004

Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients.

Surgery 2003 Dec;134(6):890-9; discussion 899-901

Department of Surgical Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0039-6060(03)00408-2DOI Listing
December 2003

Potential role for intraoperative gamma probe identification of normal parathyroid glands.

Am J Surg 2003 Dec;186(6):711-7

Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjsurg.2003.08.021DOI Listing
December 2003

The role of genetics in the surgical management of familial endocrinopathy syndromes.

J Am Coll Surg 2003 Nov;197(5):818-31

Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.froedtert.com/upload/docs/services/cancer/publica
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S107275150300813
Publisher Site
http://dx.doi.org/10.1016/j.jamcollsurg.2003.07.001DOI Listing
November 2003

Sarcomatous change after sellar irradiation in a growth hormone-secreting pituitary adenoma.

Can J Neurol Sci 2003 Nov;30(4):378-83

Department of Neurosurgery, Brain Tumor Center, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/s0317167100003115DOI Listing
November 2003

Lessons learned from the management of a rare genetic cancer.

N Engl J Med 2003 Oct;349(16):1566-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe038148DOI Listing
October 2003

Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship.

Arch Surg 2003 Apr;138(4):409-16; discussion 416

Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archsurg.138.4.409DOI Listing
April 2003

Amplification and overexpression of mutant RET in multiple endocrine neoplasia type 2-associated medullary thyroid carcinoma.

J Clin Endocrinol Metab 2003 Jan;88(1):459-63

Molecular Pathogenesis Unit, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2002-021254DOI Listing
January 2003

Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene.

J Clin Invest 2002 Dec;110(12):1849-57

Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI14218DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC151647PMC
December 2002

Improving the yield of preoperative parathyroid localization: technetium Tc 99m-sestamibi imaging after thyroid suppression.

Surgery 2002 Dec;132(6):968-74; discussion 974-5

Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1067/msy.2002.128609DOI Listing
December 2002

When "The 7-Year Itch" is indicative of an endocrine malignant condition.

Authors:
Robert F Gagel

Endocr Pract 2002 Jan-Feb;8(1):72-4

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4158/EP.8.1.72DOI Listing
August 2002

Naturally occurring heterologous trans-splicing of adenovirus RNA with host cellular transcripts during infection.

FEBS Lett 2002 Jul;522(1-3):41-6

Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0014-5793(02)02878-8DOI Listing
July 2002

Genotype-phenotype analysis in multiple endocrine neoplasia type 1.

Arch Surg 2002 Jun;137(6):641-7

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archsurg.137.6.641DOI Listing
June 2002